DIFFERENCES IN CARDIAC CALCIUM RELEASE CHANNEL (RYANODINE RECEPTOR) EXPRESSION IN MYOCARDIUM FROM PATIENTS WITH END-STAGE HEART-FAILURE CAUSED BY ISCHEMIC VERSUS DILATED CARDIOMYOPATHY

被引:170
|
作者
BRILLANTES, AM
ALLEN, P
TAKAHASHI, T
IZUMO, S
MARKS, AR
机构
[1] CUNY MT SINAI SCH MED,BROOKDALE CTR MOLEC BIOL,DIV MOLEC MED,BOX 1126,NEW YORK,NY 10029
[2] CUNY MT SINAI SCH MED,DEPT MED,DIV CARDIOL,NEW YORK,NY 10029
[3] BRIGHAM & WOMENS HOSP,DEPT ANESTHESIOL,BOSTON,MA 02115
[4] HARVARD UNIV,BETH ISRAEL HOSP,SCH MED,MOLEC MED UNIT,BOSTON,MA 02215
[5] HARVARD UNIV,BETH ISRAEL HOSP,SCH MED,DIV CARDIOVASC,BOSTON,MA 02215
关键词
IDIOPATHIC DILATED CARDIOMYOPATHY; ISCHEMIC CARDIOMYOPATHY; CALCIUM RELEASE CHANNEL; MESSENGER RNA; RYANODINE RECEPTOR;
D O I
10.1161/01.RES.71.1.18
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The molecular basis for the systolic and diastolic dysfunction characteristic of end-stage heart failure in humans remains poorly understood. It has been proposed that both abnormal calcium handling and defects in the contractile apparatus may contribute to the myocardial dysfunction. Two channels, the calcium release channel (CRC) or ryanodine receptor of the sarcoplasmic reticulum (SR), and the slow calcium channel or dihydropyridine receptor (DHPR) of the transverse tubule, play key roles in regulating intracellular calcium concentration and in excitation-contraction (E-C) coupling in the heart. The DHPR serves as the voltage sensor and plasma membrane calcium channel resulting in activation of the CRC during E-C coupling in heart muscle. In this study, we investigated the levels of CRC expression in several forms of end-stage heart failure in humans. A cardiac CRC cDNA was cloned from rabbit and used as a probe for Northern blot analyses to determine mRNA levels in the left ventricles of normal (n=4) and cardiomyopathic (n=34) human hearts from patients undergoing cardiac transplantation. Compared with normal patients, patients with ischemic cardiomyopathy (n=18) showed a 28% decrease in CRC mRNA levels (p<0.025) and patients with idiopathic dilated cardiomyopathy (n=14) a nonsignificant 12% increase. In these same hearts, alpha-actin levels were unchanged in end-stage heart failure, as has been previously reported. This is the first report indicating that the expression of the CRC mRNA is abnormal in end-stage human heart failure. The decreased expression of the CRC found specifically in patients with ischemic myopathy (but not idiopathic dilated cardiomyopathy) may, in part, explain differences in calcium handling and response to therapy observed among patients with different forms of cardiomyopathy. Decreased CRC expression could be related to abnormal contractile function in cardiomyopathic muscle resulting from ischemic insult.
引用
收藏
页码:18 / 26
页数:9
相关论文
共 50 条
  • [41] Myocardial expression analysis of osteopontin and its splice variants in patients affected by end-stage idiopathic or ischemic dilated cardiomyopathy
    Cabiati, M.
    Svezia, B.
    Matteucci, M.
    Botta, L.
    Pucci, A.
    Caselli, C.
    Lionetti, V.
    Del Ry, S.
    VASCULAR PHARMACOLOGY, 2015, 75 : 43 - 43
  • [42] Myocardial Expression Analysis of Osteopontin and Its Splice Variants in Patients Affected by End-Stage Idiopathic or Ischemic Dilated Cardiomyopathy
    Cabiati, Manuela
    Svezia, Benedetta
    Matteucci, Marco
    Botta, Luca
    Pucci, Angela
    Rinaldi, Mauro
    Caselli, Chiara
    Lionetti, Vincenzo
    Del Ry, Silvia
    PLOS ONE, 2016, 11 (08):
  • [43] TROPONIN-I GENE-EXPRESSION DURING HUMAN CARDIAC DEVELOPMENT AND IN END-STAGE HEART-FAILURE
    SASSE, S
    BRAND, NJ
    KYPRIANOU, P
    DHOOT, GK
    WADE, R
    ARAI, M
    PERIASAMY, M
    YACOUB, MH
    BARTON, PJR
    CIRCULATION RESEARCH, 1993, 72 (05) : 932 - 938
  • [44] GENE-EXPRESSION OF THE CARDIAC NA+-CA2+ EXCHANGER IN END-STAGE HUMAN HEART-FAILURE
    STUDER, R
    REINECKE, H
    BILGER, J
    ESCHENHAGEN, T
    BOHM, M
    HASENFUSS, G
    JUST, H
    HOLTZ, J
    DREXLER, H
    CIRCULATION RESEARCH, 1994, 75 (03) : 443 - 453
  • [45] DIFFERENTIAL REGULATION OF 2 TYPES OF INTRACELLULAR CALCIUM-RELEASE CHANNELS DURING END-STAGE HUMAN HEART-FAILURE
    GO, LO
    MOSCHELLA, MC
    HANDA, KK
    FYFE, BS
    MARKS, AR
    CIRCULATION, 1994, 90 (04) : LI - LI
  • [46] An embolic event to death in more than 50 percent of patients with idiopathic dilated cardiomyopathy in end-stage heart failure
    Barretto, AC
    Oliveira, MT
    Oliveira, MT
    Munhoz, RT
    Scipioni, AR
    Higuchi, ML
    Ramires, JAF
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 197A - 198A
  • [47] Myocardial capillary density is severely reduced in patients with end-stage congestive heart failure secondary to idiopathic dilated cardiomyopathy
    Tsagalou, E.
    Agapitos, E.
    Kanakakis, J.
    Alexopoulos, G.
    Ntalianis, A.
    Lazaris, N.
    Pantsios, C.
    Nanas, J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A308 - A308
  • [48] Cardiac resynchronization therapy alters left ventricular myocardial gene expression profile in patients with end-stage dilated cardiomyopathy
    Sayour, A. A. Alex Ali
    Barta, B. A.
    Olah, A.
    Ruppert, M.
    Polos, M.
    Benke, K.
    Hartyanszky, I.
    Szenthe, K.
    Banati, F.
    Szathmary, S.
    Merkely, B.
    Radovits, T.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 319 - 320
  • [49] Cardiac myocytes of hearts from patients with end-stage dilated cardiomyopathy do not contain Borrelia burgdorferi DNA
    Suedkamp, M
    Lissel, C
    Eiffert, H
    Flesch, M
    Boehm, M
    Mehlhorn, U
    Thomssen, R
    de Vivie, ER
    AMERICAN HEART JOURNAL, 1999, 138 (02) : 269 - 272
  • [50] Prevalence and Clinicopathological Phenotype of Cardiomyopathy Caused by Inborn Errors of Energy Metabolism in End-Stage Heart Failure Adult Patients Undergoing Cardiac Transplant
    Giordano, Carla
    Perli, Elena
    Pisano, Annalinda
    Pignataro, Maria Gemma
    Cerbelli, Bruna
    d'Amati, Giulia
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 300 - 301